Apeiron

Apeiron is located in two major strategic bases for new drug development: Zhangjiang, Shanghai, and the San Francisco Bay Area. At the same time, we have established significant collaborations in Oxford, UK, enabling us to leverage cutting-edge innovative technologies and top talents from around the globe to create an AI-powered, highly efficient R&D model.Our team and partners possess deep expertise in applying artificial intelligence and drug discovery, allowing us to achieve an efficient and scalable model for new drug discovery and development. From target identification to drug discovery and biomarker elucidation, we will apply AI at every stage of the research process.